Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Velusetrag (hydrochloride)

Velusetrag (TD-5108) hydrochloride is an orally active, potent and selective agonist of serotonin 5-HT4 receptor (5-HT4R), with a pKi of 7.7. Velusetrag hydrochloride exhibits no affinity (Ki>10 μM) for 5-HT2A and 5-HT2B receptors. Velusetrag hydrochloride can be used for the research of gastrointestinal diseases and Parkinson's disease[1][2][3][4][5].

Product Specifications

CAS Number

866933-51-9

Product Name Alternative

TD-5108 (hydrochloride)

UNSPSC

12352005

Target

5-HT Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Metabolic Disease; Neurological Disease

Assay Protocol

https://www.medchemexpress.com/velusetrag-hydrochloride.html

Purity

98.95

Solubility

DMSO : 220 mg/mL (ultrasonic) |H2O : 10 mg/mL (ultrasonic; warming; heat to 60°C)

Smiles

[H]Cl.O=C(C1=CC2=C(N(C(C)C)C1=O)C=CC=C2)N[C@@H]3C[C@@H](N4C[C@@H](O)CN(C)S(=O)(C)=O)CC[C@@H]4C3

Molecular Formula

C25H37ClN4O5S

Molecular Weight

541.10

References & Citations

[1]Smith JAM, et, al. The in vitro pharmacological profile of TD-5108, a selective 5-HT (4) receptor agonist with high intrinsic activity. Naunyn Schmiedebergs Arch Pharmacol. 2008 Jul;378 (1) :125-37.|[2]Beattie DT, et, al. The in vivo gastrointestinal activity of TD-5108, a selective 5-HT (4) receptor agonist with high intrinsic activity. Naunyn Schmiedebergs Arch Pharmacol. 2008 Jul;378 (1) :139-47.|[3]Ishii T, et, al. Serotonin 5-HT 4 Receptor Agonists Improve Facilitation of Contextual Fear Extinction in an MPTP-Induced Mouse Model of Parkinson's Disease. Int J Mol Sci. 2019 Oct 26;20 (21) :5340.|[4]Kuo B, et al. Velusetrag accelerates gastric emptying in subjects with gastroparesis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 study. Aliment Pharmacol Ther. 2021;53 (10) :1090-1097.|[5]Goldberg M, et al. Clinical trial: the efficacy and tolerability of velusetrag, a selective 5-HT4 agonist with high intrinsic activity, in chronic idiopathic constipation - a 4-week, randomized, double-blind, placebo-controlled, dose-response study. Aliment Pharmacol Ther. 2010;32 (9) :1102-1112.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture)

Scientific Category

Reference compound1

Clinical Information

Launched

Isoform

5-HT2 Receptor; Apolipoprotein D

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

P53 Tumor Suppressor Protein (TP53/1739), CF405S conjugate, 0.1mg/mL
BNC041739-100 1x 100 µL

P53 Tumor Suppressor Protein (TP53/1739), CF405S conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Recombinant FASN Monoclonal Antibody
AN301520L-01 50 µL

Recombinant FASN Monoclonal Antibody

Sign In for Pricing
View Details
Recombinant FASN Monoclonal Antibody
AN301520L-02 100 µL

Recombinant FASN Monoclonal Antibody

Sign In for Pricing
View Details
Human BACE1 Recombinant Rabbit monoclonal Antibody
HA725172 100 µL

Human BACE1 Recombinant Rabbit monoclonal Antibody

Sign In for Pricing
View Details
WDSUB1 (NM_001128212) Human Over-expression Lysate
LC426926 20 µg

WDSUB1 (NM_001128212) Human Over-expression Lysate

Sign In for Pricing
View Details
CK19 Polyclonal Antibody
D-AB-10360L-01 25 µL

CK19 Polyclonal Antibody

Sign In for Pricing
View Details